ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says

February 12, 1999

Creating the Modern Cancer Center

November 2, 2021

Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach.

July 9, 2004

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014

FDA Advisors Okay DDC For AIDS Treatment In Comb With AZT

May 8, 1992

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

February 17, 2012